Information about dissemination of trial results in patient information leaflets for clinicals trials in the UK and Ireland: The what and the when
<h4>Introduction</h4> Complete and understandable information is vital for informed consent and this includes how and when potential participants can expect to receive trial results. Informing participants during informed consent about the sharing of trial results is important for addres...
Main Authors: | Matilda Bjorklund, Frances Shiely, Katie Gillies |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129017/?tool=EBI |
Similar Items
-
Information about dissemination of trial results in patient information leaflets for clinicals trials in the UK and Ireland: The what and the when.
by: Matilda Bjorklund, et al.
Published: (2022-01-01) -
How much is the lack of retention evidence costing trial teams in Ireland and the UK?
by: Ellen Murphy, et al.
Published: (2022-05-01) -
How do trial teams plan for retention during the design stage of the trial? A scoping review
by: Ellen Murphy, et al.
Published: (2023-12-01) -
How do trial teams plan for retention during the design stage of the trial? A scoping review protocol
by: Ellen Murphy, et al.
Published: (2022-11-01) -
The relative importance of information items and preferred mode of delivery when disseminating results from trials to participants: A mixed‐methods study
by: Jessica Wood, et al.
Published: (2022-02-01)